Upgrade to SI Premium - Free Trial

Merck (MRK) Tops Q1 EPS by 6c; Lowers FY13 EPS Outlook; Boosts Buyback

May 1, 2013 7:03 AM
Merck & Co., Inc. (NYSE: MRK) reported Q1 EPS of $0.85, $0.06 better than the analyst estimate of $0.79. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Buybacks Hot Earnings Hot Guidance Stock Buybacks

Next Articles